Chromosomal Crossover News and Research

RSS
BioDelivery Sciences and Endo present Phase 2 data on buprenorphine HCl buccal film in patients with chronic pain

BioDelivery Sciences and Endo present Phase 2 data on buprenorphine HCl buccal film in patients with chronic pain

Egalet announces launch of OXAYDO (oxycodone HCI, USP) Tablets and IMPACT-Rx initiative

Egalet announces launch of OXAYDO (oxycodone HCI, USP) Tablets and IMPACT-Rx initiative

Particulate matter, NO2 air pollution associated with increased risk of heart attacks

Particulate matter, NO2 air pollution associated with increased risk of heart attacks

SI-BONE announces publication of results from INSITE and SIFI studies

SI-BONE announces publication of results from INSITE and SIFI studies

Researchers find effectiveness of ramelteon for treatment of sleep disturbances after TBI

Researchers find effectiveness of ramelteon for treatment of sleep disturbances after TBI

A hearty bowl of instant oatmeal helps control food intake at lunch

A hearty bowl of instant oatmeal helps control food intake at lunch

Consumption of B-GOS prebiotic has positive effect on gut microbiota, immune systems of elderly people

Consumption of B-GOS prebiotic has positive effect on gut microbiota, immune systems of elderly people

Moerae announces initiation of second MMI-0100 Phase 1 clinical trial for pulmonary disorders

Moerae announces initiation of second MMI-0100 Phase 1 clinical trial for pulmonary disorders

Houston Abilities Expo to take place on July 31-August 2 at NRG Center

Houston Abilities Expo to take place on July 31-August 2 at NRG Center

New phase III cancer treatment trial opens for patient with advanced melanoma

New phase III cancer treatment trial opens for patient with advanced melanoma

Ferrer begins Lorediplon phase IIa trial in patients with insomnia disorder

Ferrer begins Lorediplon phase IIa trial in patients with insomnia disorder

Egalet reports top-line results from Category 3 HAL study of Egalet-002

Egalet reports top-line results from Category 3 HAL study of Egalet-002

Amphetamine-based drug Evekeo effective in treating ADHD symptoms in children

Amphetamine-based drug Evekeo effective in treating ADHD symptoms in children

Egalet reports positive results from Category 3 abuse-deterrent intranasal HAL study

Egalet reports positive results from Category 3 abuse-deterrent intranasal HAL study

New 2015 Rettsyndrome.org awards announced

New 2015 Rettsyndrome.org awards announced

Human intervention trial results show that Comvita’s Olive Leaf Extract improves cardiovascular function

Human intervention trial results show that Comvita’s Olive Leaf Extract improves cardiovascular function

ADHD drug improves cognitive decline in menopausal women

ADHD drug improves cognitive decline in menopausal women

New study suggests that bright light after night shift may have potential to improve driving performance

New study suggests that bright light after night shift may have potential to improve driving performance

Stemedica receives FDA's IND approval for itMSC Phase IIa clinical trial to treat Alzheimer's disease

Stemedica receives FDA's IND approval for itMSC Phase IIa clinical trial to treat Alzheimer's disease

Ibrutinib shows promise in CLL/SLL

Ibrutinib shows promise in CLL/SLL